Pouchitis: An evolving clinical enigmaya review

Diseases of the Colon and Rectum

Volumn 52, Issue 1, 2009, Pages 140-153

  Coffey, John Calvin ^a,b   McCarthy, Eoghan ^b   Kavanagh, Eamon ^a   Redmond, Henry Paul ^a   Kirwan, William Oliver ^a  

^a University College Cork and INFANT Centre   (Ireland)

^b BEAUMONT HOSPITAL   (Ireland)

Author keywords

Etiology; Management; Pouchitis

Indexed keywords

ALBUMIN; ANTIBIOTIC AGENT; AZATHIOPRINE; CALGRANULIN; CEFTAZIDIME; CIPROFLOXACIN; CORTICOSTEROID DERIVATIVE; HERMES ANTIGEN; IMMUNOGLOBULIN G; INFLIXIMAB; INTERFERON; LACTOFERRIN; MERCAPTOPURINE; MESALAZINE; METRONIDAZOLE; NEUTROPHIL CYTOPLASMIC ANTIBODY; PROBIOTIC AGENT; REBAMIPIDE; RIFAXIMIN; STEROID; SUBSTANCE P; THROMBOCYTE ACTIVATING FACTOR; TRYPSIN INHIBITOR; TUMOR NECROSIS FACTOR;

CLINICAL FEATURE; CLINICAL TRIAL; DIGESTIVE TRACT ENDOSCOPY; DISEASE ACTIVITY; DISEASE CLASSIFICATION; DISEASE MARKER; DRUG EFFECT; DRUG EFFICACY; DYSGEUSIA; DYSPEPSIA; HISTOPATHOLOGY; HUMAN; ILEITIS; IN VIVO STUDY; MEDICAL LITERATURE; MORBIDITY; NAUSEA; NEUROPATHY; NONHUMAN; OUTCOME ASSESSMENT; PATHOGENESIS; PROTEIN FUNCTION; QUALITY OF LIFE; REVIEW; RISK FACTOR; UNSPECIFIED SIDE EFFECT; ANIMAL; COLON POUCH; PATHOPHYSIOLOGY;

ANIMALS; COLONIC POUCHES; HUMANS; POUCHITIS; RISK FACTORS;

EID: 64049087258     PISSN: 00123706     EISSN: 15300358     Source Type: Journal    
DOI: 10.1007/DCR.0b013e31819739d6     Document Type: Review

References (156)

1. Metcalf AM, Dozois RR, Kelly KA, Beart RW Jr, Wolff BG. Ileal ''J'' Pouch-anal anastomosis. Clinical outcome. Ann Surg 1985;202:735-9.
2. Nicholls RJ. Restorative proctocolectomy with ileal reservoir: indications and results. Schweiz Med Wochenschr 1990;120: 485-8.
3. Dhillon S, Loftus EV, Tremaine W, Jewell D, Harmsen WS, Sandborn W. The natural history of surgery for ulcerative colitis a population based cohort. Am J Gastroenterol 2005;100:A819.
4. Meagher AP, Farouk R, Dozois RR, Kelly KA, Pemberton JH. J ileal pouch-anal anastomosis for chronic ulcerative colitis: complications and long-term outcome in 1310 patients. Br J Surg 1998;85:800-3.
5. Tulchinsky H, Hawley PR, Nicholls J. Long-term failure after restorative proctocolectomy for ulcerative colitis. Ann Surg 2003;238:229-34.
6. Sandborn WJ. Pouchitis following ileal pouch-anal anastomosis: definition, pathogenesis, and treatment. Gastroenterology 1994;107:1856-60.
7. Belliveau P, Trudel J, Vasilevsky CA, Stein B, Gordon PH. Ileoanal anastomosis with reservoirs: complications and longterm results. Can J Surg 1999;42:345-52.
8. Stallmach A, Moser C, Hero-Gross R, et al. Pattern of mucosal adaptation in acute and chronic pouchitis. Dis Colon Rectum 1999;42:1311-7.
9. Nasmyth DG, Godwin PG, Dixon MF, Williams NS, Johnston D. Ileal ecology after pouch-anal anastomosis or ileostomy. A study of mucosal morphology, fecal bacteriology, fecal volatile fatty acids, and their interrelationship. Gastroenterology 1989;96:817-24.
10. Duffy M, O'Mahony L, Coffey JC, et al. Sulfate-reducing bacteria colonize pouches formed for ulcerative colitis but not for familial adenomatous polyposis. Dis Colon Rectum 2002;45:384-8.
11. O'Connell PR, Kelly KA. Enteric transit and absorption after canine ileostomy. Effect of pacing. Arch Surg 1987;122: 1011-7.
12. Pera M, Heppell J, Poulsom R, Teixeira FV, Williams J. Ulcer associated cell lineage glands expressing trefoil peptide genes are induced by chronic ulceration in ileal pouch mucosa. Gut 2001;48:792-6.
13. Coffey JC, Bennett MW, Wang JH, et al. Upregulation of fasfas- l (cd95/cd95l)-mediated epithelial apoptosis-a putative role in pouchitis? J Surg Res 2001;98:27-32.
14. Schouten WR. Pouchitis. Mediators Inflamm 1998;7:175-81.
15. Coffey JC, Winter DC, Neary P, et al. Quality of life after ileal pouch-anal anastomosis: an evaluation of diet and other factors using the Cleveland global quality of life instrument. Dis Colon Rectum 2002;45:30-8.
16. Nicholls RJ. Ulcerative colitis-surgical indications and treatment. Aliment Pharmacol Ther 2002;16(Suppl 4): 25-8.
17. Sagap I, Remzi FH, Hammel JP, Fazio VW. Factors associated with failure in managing pelvic sepsis after ileal pouch-anal anastomosis (IPAA)-a multivariate analysis. Surgery 2006; 140:691-704.
18. Shen B, Fazio VW, Remzi FH, et al. Comprehensive evaluation of inflammatory and noninflammatory sequelae of ileal pouch-anal anastomoses. Am J Gastroenterol 2005; 100:93-101.
19. Mignon M, Stettler C, Phillips SF. Pouchitis-a poorly understood entity. Dis Colon Rectum 1995;38:100-3.
20. Penna C, Tiret E, Kartheuser A, et al. Function of ileal J pouch-anal anastomosis in patients with familial adenomatous polyposis. Br J Surg 1993;80:765-7.
21. Tjandra JJ, Fazio VW, Church JM, et al. Similar functional results after restorative proctocolectomy in patients with familial adenomatous polyposis and mucosal ulcerative colitis. Am J Surg 1993;165:322-5.
22. Rubinstein MC, Fisher RL. Pouchitis: pathogenesis, diagnosis, and management. Gastroenterologist 1996;4:129-33.
23. Shen B. Diagnosis and treatment of patients with pouchitis. Drugs 2003;63:453-61.
24. Stahlberg D, Gullberg K, Liljeqvist L, et al. Pouchitis following pelvic pouch operation for ulcerative colitis. Incidence, cumulative risk, and risk factors. Dis Colon Rectum 1996;39:1012-8.
25. Stange EF, Buhr HJ. Pouchitis [in German]. Z Gastroenterol 2004;42:1021-4.
26. Sandborn WJ, Tremaine WJ, Batts KP, Pemberton JH, Phillips SF. Pouchitis after ileal pouch-anal anastomosis: a pouchitis disease activity index. Mayo Clin Proc 1994;69: 409-15.
27. Heuschen UA, Allemeyer EH, Hinz U, et al. Diagnosing pouchitis: comparative validation of two scoring systems in routine follow-up. Dis Colon Rectum 2002;45:776-86.
28. Moonka D, Furth EE, MacDermott RP, Lichtenstein GR. Pouchitis associated with primary cytomegalovirus infection. Am J Gastroenterol 1998;93:264-6.
29. Mignon M, Stettler C, Phillips SF. Ileo-anal ''pouchitis'': a still misunderstood pathology [in French]. Ann Chir 1993;47: 1049-53.
30. Stein RB, Lichtenstein GR. Complications after ileal pouchanal anastomosis. Semin Gastrointest Dis 2000;11:2-9.
31. Keighley MR. The final diagnosis in pouch patients for presumed ulcerative colitis may change to Crohn's disease: patients should be warned of the consequences. Acta Chir Iugosl 2000;47:27-31.
32. Apel R, Cohen Z, Andrews CW Jr, McLeod R, Steinhart H, Odze RD. Prospective evaluation of early morphological changes in pelvic ileal pouches. Gastroenterology 1994;107:435-43.
33. Svaninger G, Nordgren S, Oresland T, Hulten L. Incidence and characteristics of pouchitis in the Kock continent ileostomy and the pelvic pouch. Scand J Gastroenterol 1993; 28:695-700.
34. Hurst RD, Molinari M, Chung TP, Rubin M, Michelassi F. Prospective study of the incidence, timing and treatment of pouchitis in 104 consecutive patients after restorative proctocolectomy. Arch Surg 1996;131:497-500
35. Cheifetz A, Itzkowitz S. The diagnosis and treatment of pouchitis in inflammatory bowel disease. J Clin Gastroenterol 2004;38:S44-50.
36. Lovegrove RE, Tilney HS, Heriot AG, et al. A comparison of adverse events and functional outcomes after restorative proctocolectomy for familial adenomatous polyposis and ulcerative colitis. Dis Colon Rectum 2006;49:1293-306.
37. Lohmuller JL, Pemberton JH, Dozois RR, Ilstrup D, van Heerden J. Pouchitis and extraintestinal manifestations of inflammatory bowel disease after ileal pouch-anal anastomosis. Ann Surg 1990;211:622-9.
38. Simchuk EJ, Thirlby RC. Risk factors and true incidence of pouchitis in patients after ileal pouch-anal anastomoses. World J Surg 2000;24:851-6.
39. Achkar JP, Al-Haddad M, Lashner B, et al. Differentiating risk factors for acute and chronic pouchitis. Clin Gastroenterol Hepatol 2005;3:60-6.
40. Joelsson M, Benoni C, Oresland T. Does smoking influence the risk of pouchitis following ileal pouch anal anastomosis for ulcerative colitis? Scand J Gastroenterol 2006;41:929-33.
41. Abdelrazeq AS, Kandiyil N, Botterill ID, et al. Predictors for acute and chronic pouchitis following restorative proctocolectomy for ulcerative colitis. Colorectal Dis 2007:Nov; doi:10.1111/j.1463-1318.2007.01413.x
42. Abdelrazeq AS, Lund JN, Leveson SH. Pouchitis-associated pyoderma gangrenosum following restorative proctocolectomy for ulcerative colitis. Eur J Gastroenterol Hepatol 2004;16:1057-8.
43. Ferrante M, Declerck S, De Hertogh G, et al. Outcome after proctocolectomy with ileal pouch-anal anastomosis for ulcerative colitis. Inflamm Bowel Dis 2008;14:20-8.
44. Aisenberg J, Legnani PE, Nilubol N, et al. Are p-ANCA, ASCA, or cytokine gene polymorphisms associated with pouchitis? Long-term follow-up in 102 ulcerative colitis patients. Am J Gastroenterol 2004;99:432-41.
45. Brett PM, Yasuda N, Yiannakou JY, et al. Genetic and immunological markers in pouchitis. Eur J Gastroenterol Hepatol 1996;8:951-5.
46. Carter MJ, Di Giovine FS, Cox A, et al. The interleukin 1 receptor antagonist gene allele 2 as a predictor of pouchitis following colectomy and IPAA in ulcerative colitis. Gastroenterology 2001;121:805-11.
47. ter Borg EJ, Nadorp JH, Elbers JR. Ileal pouch arthritis: a case report. Eur J Gastroenterol Hepatol 1996;8:957-9.
48. Tamboli CP, Caucheteux C, Cortot A, Colombel JF, Desreumaux P. Probiotics in inflammatory bowel disease: a critical review. Best Pract Res Clin Gastroenterol 2003;17: 805-20.
49. Kuhbacher T, Schreiber S, Runkel N. Pouchitis: pathophysiology and treatment. Int J Colorectal Dis 1998;13:196-207.
50. Kuhbacher T. Pouchitis and the risk of cancer? Int J Colorectal Dis 2001;16:131.
51. Shen B, Fazio VW, Remzi FH, et al. Risk factors for clinical phenotypes of Crohn's disease of the ileal pouch. Am J Gastroenterol 2006;101:2760-8.
52. Evgenikos N, Bartolo DC, Hamer-Hodges DW, Ghosh S. Assessment of ileoanal pouch inflammation by interleukin 1 beta and interleukin 8 concentrations in the gut lumen. Dis Colon Rectum 2002;45:249-55.
53. Mann SD, Pitt J, Springall RG, Thillainayagam AV. Clostridium difficile infection-an unusual cause of refractory pouchitis: report of a case. Dis Colon Rectum 2003;46:267-70.
54. Munoz-Juarez M, Pemberton JH, Sandborn WJ, et al. Misdiagnosis of specific cytomegalovirus infection of the ileoanal pouch as refractory idiopathic chronic pouchitis: report of two cases. Dis Colon Rectum 1999;42:117-20.
55. Shen B, Bennett AE, Fazio VW, et al. Collagenous pouchitis. Dig Liver Dis 2006;38:704-9.
56. Shen B, Goldblum JR, Hull TL, et al. Clostridium difficileassociated pouchitis. Dig Dis Sci 2006;51:2361-4.
57. Hata K, Watanabe T, Shinozaki M, Nagawa H. Patients with extraintestinal manifestations have a higher risk of developing pouchitis in ulcerative colitis: Multivariate analysis. Scand J Gastroenterol 2003;38:1055-8.
58. Teixeira WG, da Silva JH, Teixeira MG, et al. Pouchitis: extracolonic manifestation of ulcerative colitis? Rev Hosp Clin Fac Med Sao Paulo 1999;54:155-8.
59. Nakamura M, Ikeuchi H, Nakano H, et al. Postoperative joint symptoms: a risk factor for pouchitis in ulcerative colitis patients. Dig Surg 2006;23:60-4.
60. Thomas PD, Keat AC, Forbes A, et al. Extraintestinal manifestations of ulcerative colitis following restorative proctocolectomy. Eur J Gastroenterol Hepatol 1999;11: 1001-5.
61. Penna C, Dozois R, Tremaine W, et al. Pouchitis after ileal pouch-anal anastomosis for ulcerative colitis occurs with increased frequency in patients with associated primary sclerosing cholangitis. Gut 1996;38:234-9.
62. Di Febo G, Miglioli M, Lauri A, et al. Endoscopic assessment of acute inflammation of the ileal reservoir after restorative ileo-anal anastomosis. Gastrointest Endosc 1990;36:6-9.
63. Wolf JM, Achkar JP, Lashner BA, et al. Afferent limb ulcers predict Crohn's disease in patients with ileal pouch-anal anastomosis. Gastroenterology 2004;126:1686-91.
64. Thompson-Fawcett MW, Mortensen NJ, Warren BF. ''Cuffitis'' and inflammatory changes in the columnar cuff, anal transitional zone, and ileal reservoir after stapled pouch-anal anastomosis. Dis Colon Rectum 1999;42:348-55.
65. McMullen K, Hicks TC, Ray JE, et al. Complications associated with ileal pouch-anal anastomosis. World J Surg 1991;15:763-6.
66. Shen B, Achkar JP, Lashner BA, et al. Irritable pouch syndrome: a new category of diagnosis for symptomatic patients with ileal pouch-anal anastomosis. Am J Gastroenterol 2002;97:972-7.
67. Kmiot WA, Youngs D, Tudor R, Thompson H, Keighley MR. Mucosal morphology, cell proliferation and fecal bacteriology in acute pouchitis. Br J Surg 1993;80:1445-9.
68. Shepherd NA, Jass JR, Duval I, et al. Restorative proctocolectomy with ileal reservoir: pathological and histochemical study of mucosal biopsy specimens. J Clin Pathol 1987;40: 601-7.
69. Nicholls RJ, Banerjee AK. Pouchitis: risk factors, etiology, and treatment. World J Surg 1998;22:347-51.
70. de Silva HJ, Millard PR, Soper N, et al. Effects of the fecal stream and stasis on the ileal pouch mucosa. Gut 1991;32: 1166-9.
71. Lerch MM, Braun J, Harder M, et al. Postoperative adaptation of the small intestine after total colectomy and J-pouch-anal anastomosis. Dis Colon Rectum 1989;32:600-8.
72. Smith FM, Coffey JC, Kell MR, et al. A characterization of anaerobic colonization and associated mucosal adaptations in the undiseased ileal pouch. Colorectal Dis 2005;7:563-70.
73. Ogawa H, Binion DG. Effect of enteric flora on inflammatory and angiogenic mechanisms in human intestinal microvascular endothelial cells. Front Biosci 2005;10:94-8.
74. Shi HN, Walker A. Bacterial colonization and the development of intestinal defences. Can J Gastroenterol 2004;18: 493-500.
75. Kobayashi K, Kashima K, Higuchi K, Arakawa T. The mechanisms of gastrointestinal mucosal injury and repair. [in Japanese] Nippon Rinsho 1998;56:2215-22.
76. Knupper N, Straub E, Terpe HJ, Vestweber KH. Adenocarcinoma of the ileoanal pouch for ulcerative colitis-a complication of severe chronic atrophic pouchitis? Int J Colorectal Dis 2006;21:478-82.
77. Hagemann T, Balwill B, Lawrence T. Inflammation and cancer: a double-edged sword. Cancer Cell 2007;12: 300-1.
78. Schultz AC, Bojarski C, Buhr HJ, Kroesen AJ. Occurrence of adenomas in the pouch and small intestine of FAP patients after proctocolectomy with ileoanal pouch construction. Int J Colorectal Dis 2008;23:437-41.
79. Das P, Johnson MW, Tekkis PP, Nicholls RJ. Risk of dysplasia and adenocarcinoma following restorative proctocolectomy for ulcerative colitis. Colorectal Dis 2007;9: 15-27.
80. Veress B, Reinholt FP, Lindquist K, et al. Long-term histomorphological surveillance of the pelvic ileal pouch: dysplasia develops in a subgroup of patients. Gastroenterology 1995;109:1090-7.
81. Kmiot WA, Williams MR, Keighley MR. Pouchitis following colectomy and ileal reservoir construction for familial adenomatous polyposis. Br J Surg 1990;77:1283.
82. Thomas P, Rihani H, Roseth A, et al. Assessment of ileal pouch inflammation by single-stool calprotectin assay. Dis Colon Rectum 2000;43:214-20.
83. Stallmach A, van Look M, Scheiffele F, et al. IgG, albumin, and sCd44 in whole-gut lavage fluid are useful clinical markers for assessing the presence and activity of pouchitis. Int J Colorectal Dis 1999;14:35-40.
84. Evgenikos N, Bartolo DC, Hamer-Hodges DW, Ghosh S. Immunoglobulin and albumin levels in whole gut lavage fluid provide an objective measure of pouch ileitis. Br J Surg 2000;87:808-13.
85. Denizot Y, Chaussade S, Couturier D. Fecal platelet-activating factor (paf). A marker of digestive inflammatory disorders [in French]. Presse Med 1993;22:1704-6.
86. Denizot Y, Chaussade S, Colombel JF, et al. Presence pafacether mediator of inflammation in stools of patients with inflammatory enterocolitis [in French]. C R Acad Sci III 1991;312:329-33.
87. Boerr LA, Sambuelli AM, Sugai E, et al. Fecal alpha 1- antitrypsin concentration in the diagnosis and management of patients with pouchitis. Eur J Gastroenterol Hepatol 1995;7:129-33.
88. Boerr LA, Sambuelli AM, Filinger E, et al. Increased mucosal levels of leukotriene B4 in pouchitis: evidence for a persistent inflammatory state. Eur J Gastroenterol Hepatol 1996;8: 57-61.
89. Konikoff MR, Denson LA. Role of fecal calprotectin as a biomarker of intestinal inflammation in inflammatory bowel disease. Inflamm Bowel Dis 2006;12:524-34.
90. Laake KO, Line PD, Grzyb K, et al. Assessment of mucosal inflammation and blood flow in response to four weeks intervention with probiotics in patients operated with a Jconfigurated ileal-pouch-anal- anastomosis (IPAA). Scand J Gastroenterol 2004;39:1228-35.
91. Laake KO, Line PD, Aabakken L, et al. Assessment of mucosal inflammation and circulation in response to probiotics in patients operated with ileal pouch anal anastomosis for ulcerative colitis. Scand J Gastroenterol 2003;38:409-14.
92. Parsi MA, Shen B, Achkar JP, et al. Fecal lactoferrin for diagnosis of symptomatic patients with ileal pouch-anal anastomosis. Gastroenterology 2004;126:1280-6.
93. Helwig U, Gionchetti P, Rizzello F, et al. Cxc and cc chemokine expression in inflamed and noninflamed pelvic ileal pouch tissue. Int J Colorectal Dis 2004;19:165-70.
94. Bulois P, Tremaine WJ, Maunoury V, et al. Pouchitis is associated with mucosal imbalance between interleukin-8 and interleukin-10. Inflamm Bowel Dis 2000;6:157-64.
95. Ulisse S, Gionchetti P, D'Alo S, et al. Expression of cytokines, inducible nitric oxide synthase, and matrix metalloproteinases in pouchitis: effects of probiotic treatment. Am J Gastroenterol 2001;96:2691-9.
96. Madsen K, Cornish A, Soper P, et al. Probiotic bacteria enhance murine and human intestinal epithelial barrier function. Gastroenterology 2001;121:580-91.
97. Aisenberg J, Wagreich J, Shim J, et al. Perinuclear antineutrophil cytoplasmic antibody and refractory pouchitis. A case-control study. Dig Dis Sci 1995;40:1866-72.
98. Yasuda N, Thomas P, Ellis H, et al. Perinuclear antineutrophil cytoplasmic antibodies in ulcerative colitis after restorative proctocolectomy do not correlate with the presence of pouchitis. Scand J Gastroenterol 1998;33:509-13.
99. Kuisma J, Mentula S, Luukkonen P, et al. Factors associated with ileal mucosal morphology and inflammation in patients with ileal pouch-anal anastomosis for ulcerative colitis. Dis Colon Rectum 2003;46:1476-83.
100. Fleshner PR, Vasiliauskas EA, Kam LY, et al. High level perinuclear antineutrophil cytoplasmic antibody (pANCA) in ulcerative colitis patients before colectomy predicts the development of chronic pouchitis after ileal pouch-anal anastomosis. Gut 2001;49:671-7.
101. Stallmach A, Schafer F, Hoffmann S, et al. Increased state of activation of cd4 positive t cells and elevated interferon gamma production in pouchitis. Gut 1998;43:499-5.
102. Keranen U, Jarvinen H, Kiviluoto T, Kivilaakso E, Soinila S. Substance P and vasoactive intestinal polypeptide-immunoreactive innervation in normal and inflamed pouches after restorative proctocolectomy for ulcerative colitis. Dig Dis Sci 1996;41:1658-64.
103. Keranen U, Jarvinen H, Karkkainen P, Kiviluoto T, Kivilaakso E, Soinila S. Substance P-an underlying factor for pouchitis? Prospective study of substance P and vasoactive intestinal polypeptide-immunoreactive innervation and mast cells. Dig Dis Sci 1996;41:1665-71.
104. Biancone L, Palmieri G, Lombardi A, et al. Cytoskeletal proteins and resident flora. Dig Liver Dis 2002;34(Suppl 2): S34-6.
105. Biancone L, Palmieri G, Lombardi A, et al. Tropomyosin expression in the ileal pouch: a relationship with the development of pouchitis in ulcerative colitis. Am J Gastroenterol 2003;98:2719-26.
106. Shebani KO, Stucchi AF, McClung JP, et al. Role of stasis and oxidative stress in ileal pouch inflammation. J Surg Res 2000;90:67-75.
107. Levin KE, Pemberton JH, Phillips SF, et al. Role of oxygenfree radicals in the etiology of pouchitis. Dis Colon Rectum 1992;35:452-6.
108. Lichtman SN, Wang J, Hummel B, et al. A rat model of ileal pouch-rectal anastomosis. Inflamm Bowel Dis 1998;4:187-95.
109. Pitcher MC, Beatty ER, Cummings JH. The contribution of sulfate reducing bacteria and 5-aminosalicylic acid to fecal sulfide in patients with ulcerative colitis. Gut 2000;46:64-72.
110. Lewis S, Brazier J, Beard D, Nazem N, Proctor D. Effects of metronidazole and oligofructose on fecal concentrations of sulphate-reducing bacteria and their activity in human volunteers. Scand J Gastroenterol 2005;40:1296-303.
111. Ohge H, Takesue Y, Sueda T, Madoff RD, Levitt MD. Fecal hydrogen sulfide: toxin? Or just odoriferous gas [in Japanese]? Jpn J Antibiot 2005;58:193-9.
112. Ohge H, Furne JK, Springfield J, Rothenberger DA, Madoff RD, Levitt MD. Association between fecal hydrogen sulfide production and pouchitis. Dis Colon Rectum 2005;48: 469-75.
113. Yamamoto T, Umegae S, Kitagawa T, Matsumoto K. The impact of the fecal stream and stasis on immunologic reactions in ileal pouch after restorative proctocolectomy for ulcerative colitis: a prospective, pilot study. Am J Gastroenterol 2005;100:2248-53.
114. Heppell J, Belliveau P, Taillefer R, Dube S, Derbekyan V. Quantitative assessment of pelvic ileal reservoir emptying with a semisolid radionuclide enema. A correlation with clinical outcome. Dis Colon Rectum 1987;30:81-5.
115. Wood MJ, Hyman N, Hebert JC, Blaszyk H. Catastrophic clostridium difficile enteritis in a pelvic pouch patient: report of a case. J Gastrointest Surg 2008;12:350-2.
116. Shanahan F. Probiotics and inflammatory bowel disease: is there a scientific rationale? Inflamm Bowel Dis 2000;6:107-15.
117. Schultz M, Sartor RB. Probiotics and inflammatory bowel diseases. Am J Gastroenterol 2000;95:S19-21.
118. Sartor RB. Therapeutic manipulation of the enteric microflora in inflammatory bowel diseases: antibiotics, probiotics, and prebiotics. Gastroenterology 2004;126:1620-33.
119. Sartor RB. Targeting enteric bacteria in treatment of inflammatory bowel diseases: why, how, and when. Curr Opin Gastroenterol 2003;19:358-65.
120. Sartor RB. Probiotics in chronic pouchitis: restoring luminal microbial balance. Gastroenterology 2000;119:584-7.
121. Kienle P, Weitz J, Reinshagen S, et al. Association of decreased perfusion of the ileoanal pouch mucosa with early postoperative pouchitis and local septic complications. Arch Surg 2001;136:1124-30.
122. Shepherd NA. The pelvic ileal reservoir: pathology and pouchitis. Neth J Med 1990;37(Suppl 1):S57-64.
123. Cook SI, Sellin JH. Short chain fatty acids in health and disease. Aliment Pharmacol Ther 1998;12:499-507.
124. Sandborn WJ, Tremaine WJ, Batts KP, et al. Fecal bile acids, short-chain fatty acids, and bacteria after ileal pouch-anal anastomosis do not differ in patients with pouchitis. Dig Dis Sci 1995;40:1474-83.
125. Wischmeyer P, Pemberton JH, Phillips SF. Chronic pouchitis after ileal pouch-anal anastomosis: responses to butyrate and glutamine suppositories in a pilot study. Mayo Clin Proc 1993;68:978-81.
126. Fozard BJ, Pemberton JH. Results of pouch surgery after ileoanal anastomosis: the implications of pouchitis. World J Surg 1992;16:880-84.
127. Shen B, Achkar JP, Lashner BA, et al. A randomized clinical trial of ciprofloxacin and metronidazole to treat acute pouchitis. Inflamm Bowel Dis 2001;7:301-5.
128. Scott AD, Phillips RK. Ileitis and pouchitis after colectomy for ulcerative colitis. Br J Surg 1989;76:668-9.
129. Nygaard K, Bergan T, Bjorneklett A, et al. Topical metronidazole treatment in pouchitis. Scand J Gastroenterol 1994;29:462-7.
130. Sartor RB. Probiotic therapy of intestinal inflammation and infections. Curr Opin Gastroenterol 2005;21:44-50.
131. Gionchetti P, Rizzello F, Helwig U, et al. Prophylaxis of pouchitis onset with probiotic therapy: a doubleblind, placebo-controlled trial. Gastroenterology 2003;124: 1202-9.
132. Gionchetti P, Rizzello F, Poggioli G, et al. Probiotic therapy to prevent pouchitis onset. Dis Colon Rectum 2005;48: 1493-4.
133. Goossens D, Jonkers D, Stobberingh E, et al. Probiotics in gastroenterology: indications and future perspectives. Scand J Gastroenterol Suppl 2003:15-23.
134. Gosselink MP, Schouten WR, van Lieshout LM, et al. Delay of the first onset of pouchitis by oral intake of the probiotic strain Lactobacillus rhamnosus GG. Dis Colon Rectum 2004;47:876-84.
135. Mimura T, Rizzello F, Helwig U, et al. Once daily high dose probiotic therapy (VSL#3) for maintaining remission in recurrent or refractory pouchitis. Gut 2004;53:108-14.
136. Chapman TM, Plosker GL, Figgitt DP. VSL#3 probiotic mixture: a review of its use in chronic inflammatory bowel diseases. Drugs 2006;66:1371-87.
137. Chapman TM, Plosker GL, Figgitt DP. Spotlight on VSL#3 probiotic mixture in chronic inflammatory bowel diseases. BioDrugs 2007;21:61-3.
138. Gionchetti P, Rizzello F, Poggioli G, et al. Oral budesonide in the treatment of chronic refractory pouchitis. Aliment Pharmacol Ther 2007;25:1231-6.
139. Sandborn W, McLeod R, Jewell D. Pharmacotherapy for inducing and maintaining remission in pouchitis. Cochrane Database Syst Rev 2000:CD001176.
140. Gionchetti P, Rizzello F, Lammers KM, et al. Antibiotics and probiotics in treatment of inflammatory bowel disease. World J Gastroenterol 2006;12:3306-13.
141. Isaacs KL, Sandler RS, Abreu M, et al. Rifaximin for the treatment of active pouchitis: a randomized, double-blind, placebo-controlled pilot study. Inflamm Bowel Dis 2007;13: 1250-5.
142. Viscido A, Caprilli R. Development of fistulae in ileo-anal pouch does not necessarily indicate Crohn's disease. Am J Gastroenterol 2004;99:2066-7.
143. Viscido A, Habib FI, Kohn A, et al. Infliximab in refractory pouchitis complicated by fistulae following ileo-anal pouch for ulcerative colitis. Aliment Pharmacol Ther 2003;17:1263-71.
144. Viscido A, Kohn A, Papi C, Caprilli R. Management of refractory fistulizing pouchitis with infliximab. Eur Rev Med Pharmacol Sci 2004;8:239-46.
145. Lahat G, Halperin D, Barazovsky E, et al. Immunomodulatory effects of ciprofloxacin in TNBS-induced colitis in mice. Inflamm Bowel Dis 2007;13:557-65.
146. Shen B, Fazio VW, Remzi FH, et al. Combined ciprofloxacin and tinidazole therapy in the treatment of chronic refractory pouchitis. Dis Colon Rectum 2007;50:498-508.
147. Arnott ID, McDonald D, Williams A, Ghosh S. Clinical use of infliximab in Crohn's disease: the Edinburgh experience. Aliment Pharmacol Ther 2001;15:1639-46.
148. Miglioli M, Barbara L, Di Febo G, et al. Topical administration of 5-aminosalicylic acid: A therapeutic proposal for the treatment of pouchitis. N Engl J Med 1989;320:257.
149. Shepherd NA, Hulten L, Tytgat GN, et al. Pouchitis. Int J Colorectal Dis 1989;4:205-29.
150. Miyata M, Konagaya T, Kakumu S, Mori T. Successful treatment of severe pouchitis with rebamipide refractory to antibiotics and corticosteroids: a case report. World J Gastroenterol 2006;12:656-8.
151. Otte JM, Boser S, Brunke G, et al. Expression of keratinocyte growth factor and its receptor in adaptive changes of ileorectal pouch mucosa. Scand J Gastroenterol 2005;40:1066-75.
152. Lichtenstein GR, Cohen R, Yamashita B, Diamond RH. Quality of life after proctocolectomy with ileoanal anastomosis for patients with ulcerative colitis. J Clin Gastroenterol 2006;40:669-77.
153. Tiainen J, Matikainen M. Health-related quality of life after ileal J-pouch-anal anastomosis for ulcerative colitis: longterm results. Scand J Gastroenterol 1999;34:601-5.
154. Scarpa M, Angriman I, Ruffolo C, et al. Health-related quality of life after restorative proctocolectomy for ulcerative colitis: long-term results. World J Surg 2004;28:124-9.
155. Macafee DA, Abercrombie JF, Maxwell-Armstrong C. Pouchitis. Colorectal Dis 2004;6:142-52.
156. Takahashi T, Ponce de Leon S, Cardenas S, et al. Quality of life after ileo-anal anastomosis [in Spanish]. Rev Invest Clin 2002;54:397-402.